BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niu XK, He XF. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma. World J Gastroenterol 2021; 27(2): 189-207 [PMID: 33510559 DOI: 10.3748/wjg.v27.i2.189]
URL: https://www.wjgnet.com/1007-9327/full/v27/i2/189.htm
Number Citing Articles
1
Jie Peng, Jinhua Huang, Guijia Huang, Jing Zhang. Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep LearningFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.730282
2
Wei-Li Xia, Shi-Jun Xu, Yuan Guo, Xiao-Hui Zhao, Hong-Tao Hu, Yan Zhao, Quan-Jun Yao, Lin Zheng, Dong-Yang Zhang, Chen-Yang Guo, Wei-Jun Fan, Hai-Liang Li. Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1014653
3
Qifan He, Jian Yang, Yonghai Jin. Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular CarcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.869993
4
Chun Jiang, Yi-Qi Cai, Jia-Jia Yang, Can-Yu Ma, Jia-Xi Chen, Lan Huang, Ze Xiang, Jian Wu. Radiomics in the diagnosis and treatment of hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2023; 22(4): 346 doi: 10.1016/j.hbpd.2023.03.010
5
Chao Yang, Hong-cai Yang, Yin-gen Luo, Fu-tian Li, Tian-hao Cong, Yu-jie Li, Feng Ye, Xiao Li. Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE RefractorinessCardioVascular and Interventional Radiology 2024; 47(7): 964 doi: 10.1007/s00270-024-03730-z
6
Na Zhang, Xiao-Feng He, Xiang-Ke Niu. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysisWorld Journal of Methodology 2023; 13(4): 345-358 doi: 10.5662/wjm.v13.i4.345
7
Yanmei Dai, Huijie Jiang, Shi-Ting Feng, Yuwei Xia, Jinping Li, Sheng Zhao, Dandan Wang, Xu Zeng, Yusi Chen, Yanjie Xin, Dongmin Liu. Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 273 doi: 10.2147/JHC.S351077
8
Tianhao Cong, Chao Yang, Qi Cao, Jinrui Ren, Yingen Luo, Pei Yuan, Bo Zheng, Yu Liu, Hongcai Yang, Wendi Kang, Aixin Ou, Xiao Li. The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein LevelsJournal of Hepatocellular Carcinoma 2024; : 95 doi: 10.2147/JHC.S441179
9
Mingqi Zhang, Bingling Kuang, Jingxuan Zhang, Jingyi Peng, Haoming Xia, Xiaobin Feng, Liang Peng. Enhancing prognostic prediction in hepatocellular carcinoma post-TACE: a machine learning approach integrating radiomics and clinical featuresFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1419058
10
Cyra Y Kang, Samantha E Duarte, Hye Sung Kim, Eugene Kim, Jonghanne Park, Alice Daeun Lee, Yeseul Kim, Leeseul Kim, Sukjoo Cho, Yoojin Oh, Gahyun Gim, Inae Park, Dongyup Lee, Mohamed Abazeed, Yury S Velichko, Young Kwang Chae. Artificial Intelligence-based Radiomics in the Era of Immuno-oncologyThe Oncologist 2022; 27(6): e471 doi: 10.1093/oncolo/oyac036
11
Zhiyuan Bo, Jiatao Song, Qikuan He, Bo Chen, Ziyan Chen, Xiaozai Xie, Danyang Shu, Kaiyu Chen, Yi Wang, Gang Chen. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinomaComputers in Biology and Medicine 2024; 173: 108337 doi: 10.1016/j.compbiomed.2024.108337
12
Vincenza Granata, Roberta Fusco, Sergio Venazio Setola, Igino Simonetti, Diletta Cozzi, Giulia Grazzini, Francesca Grassi, Andrea Belli, Vittorio Miele, Francesco Izzo, Antonella Petrillo. An update on radiomics techniques in primary liver cancersInfectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00422-6
13
Dan-Dan Wang, Jin-Feng Zhang, Lin-Han Zhang, Meng Niu, Hui-Jie Jiang, Fu-Cang Jia, Shi-Ting Feng. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter studyHepatobiliary & Pancreatic Diseases International 2023; 22(6): 594 doi: 10.1016/j.hbpd.2022.11.005
14
Sonia Triggiani, Maria T. Contaldo, Giulia Mastellone, Maurizio Cè, Anna M. Ierardi, Gianpaolo Carrafiello, Michaela Cellina. The Role of Artificial Intelligence and Texture Analysis in Interventional Radiological Treatments of Liver Masses: A Narrative Review Critical Reviews™ in Oncogenesis 2024; 29(2): 37 doi: 10.1615/CritRevOncog.2023049855
15
Natally Horvat, Joao Miranda, Maria El Homsi, Jacob J. Peoples, Niamh M. Long, Amber L. Simpson, Richard K. G. Do. A primer on texture analysis in abdominal radiologyAbdominal Radiology 2021; 47(9): 2972 doi: 10.1007/s00261-021-03359-3
16
Kaige Deng, Tong Chen, Zijian Leng, Fan Yang, Tao Lu, Jingying Cao, Weixuan Pan, Yongchang Zheng. Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysisLa radiologia medica 2024; 129(8): 1099 doi: 10.1007/s11547-024-01840-9
17
Gang Peng, Xiao-yu Huang, Ya-nan Wang, Xiao-jing Cao, Xiang Zhou. Prognostic Value of Preoperative MRI-derived 3D Quantitative Tumor Arterial Burden in Patients with Hepatocellular Carcinoma Receiving Transarterial ChemoembolizationRadiology: Imaging Cancer 2024; 6(3) doi: 10.1148/rycan.230167
18
Faraaz Khan, Keaton Jones, Paul Lyon. Immune checkpoint inhibition: a future guided by radiologyThe British Journal of Radiology 2023;  doi: 10.1259/bjr.20220565
19
Jia-Wei Zhong, Dan-Dan Nie, Ji-Lan Huang, Rong-Guang Luo, Qing-He Cheng, Qiao-Ting Du, Gui-Hai Guo, Liang-Liang Bai, Xue-Yun Guo, Yan Chen, Si-Hai Chen. Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF scoreDiscover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00803-2
20
Tian-You Chen, Zong-Guo Yang, Ying Li, Mao-Quan Li. Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinomaWorld Journal of Radiology 2023; 15(4): 89-97 doi: 10.4329/wjr.v15.i4.89
21
Jingwei Wei, Hanyu Jiang, Yu Zhou, Jie Tian, Felipe S. Furtado, Onofrio A. Catalano. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinomaDigestive and Liver Disease 2023; 55(7): 833 doi: 10.1016/j.dld.2022.12.015
22
Vincenza Granata, Roberta Grassi, Roberta Fusco, Andrea Belli, Carmen Cutolo, Silvia Pradella, Giulia Grazzini, Michelearcangelo La Porta, Maria Chiara Brunese, Federica De Muzio, Alessandro Ottaiano, Antonio Avallone, Francesco Izzo, Antonella Petrillo. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinomaInfectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00393-0
23
Yuze Li, Ziming Xu, Chao An, Huijun Chen, Xiao Li. Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial ChemoembolizationJournal of Personalized Medicine 2022; 12(2): 248 doi: 10.3390/jpm12020248
24
Junhui Yang, Yunjie Zhang, Yifan Kong, Jiawei Lin, Guoqing Zhu, Hao Zhang, Zhijie Yu, Pixu Liu, Jinglin Xia. Diagnostic value of serum inflammatory markers in predicting early refractoriness of transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer Stage 0, A, and B hepatocellular carcinomaBrazilian Journal of Medical and Biological Research 2024; 57 doi: 10.1590/1414-431x2024e13661
25
Cody Criss, Arpit M Nagar, Mina S Makary. Hepatocellular carcinoma: State of the art diagnostic imagingWorld Journal of Radiology 2023; 15(3): 56-68 doi: 10.4329/wjr.v15.i3.56
26
Xiang-Ke Niu, Xiao-Feng He. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular CarcinomaJournal of Personalized Medicine 2022; 12(9): 1375 doi: 10.3390/jpm12091375